igalmi
(DEXMEDETOMIDINE)BioXcel Therapeutics, Inc.
Usage: IGALMI is indicated for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Its safety and effectiveness have not been established beyond 24 hours from the first dose.